PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $31,350,000 | -25.3% | 8,250,000 | 0.0% | 0.27% | -4.9% |
| Q4 2019 | $41,993,000 | +13.0% | 8,250,000 | +12.2% | 0.28% | +0.7% |
| Q3 2019 | $37,154,000 | +8.6% | 7,350,000 | +32.6% | 0.28% | +26.6% |
| Q2 2019 | $34,203,000 | +75.5% | 5,543,386 | +32.0% | 0.22% | +51.0% |
| Q1 2019 | $19,492,000 | +10.5% | 4,200,820 | 0.0% | 0.15% | +14.0% |
| Q4 2018 | $17,643,000 | -22.1% | 4,200,820 | +16.3% | 0.13% | -3.7% |
| Q3 2018 | $22,652,000 | +6.3% | 3,612,820 | +36.3% | 0.13% | +1.5% |
| Q2 2018 | $21,315,000 | – | 2,651,100 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|